Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Cyanotech Corporation (CYAN)CYAN

Upturn stock ratingUpturn stock rating
Cyanotech Corporation
$0.35
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: CYAN (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: -46.04%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 23
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/20/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: -46.04%
Avg. Invested days: 23
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 2.94M USD
Price to earnings Ratio -
1Y Target Price 14
Dividends yield (FY) -
Basic EPS (TTM) -0.75
Volume (30-day avg) 5966
Beta 0.03
52 Weeks Range 0.18 - 1.02
Updated Date 11/20/2024
Company Size Small-Cap Stock
Market Capitalization 2.94M USD
Price to earnings Ratio -
1Y Target Price 14
Dividends yield (FY) -
Basic EPS (TTM) -0.75
Volume (30-day avg) 5966
Beta 0.03
52 Weeks Range 0.18 - 1.02
Updated Date 11/20/2024

Earnings Date

Report Date 2024-11-06
When BeforeMarket
Estimate -
Actual -
Report Date 2024-11-06
When BeforeMarket
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -9.84%
Return on Equity (TTM) -39.69%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 13137226
Price to Sales(TTM) 0.11
Enterprise Value to Revenue 0.56
Enterprise Value to EBITDA 21.94
Shares Outstanding 7155860
Shares Floating 4602568
Percent Insiders 38.27
Percent Institutions -
Trailing PE -
Forward PE -
Enterprise Value 13137226
Price to Sales(TTM) 0.11
Enterprise Value to Revenue 0.56
Enterprise Value to EBITDA 21.94
Shares Outstanding 7155860
Shares Floating 4602568
Percent Insiders 38.27
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Cyanotech Corporation: A Comprehensive Overview

Company Profile:

Detailed History and Background:

Founded in 1981, Cyanotech Corporation is a Hawaii-based biotechnology company specializing in the cultivation and production of natural products derived from microalgae. It has a long history of innovation, pioneering the commercial cultivation of microalgae in the world.

Core Business Areas:

  • Natural Astaxanthin: Cyanotech is the world's leading producer of natural astaxanthin, a powerful antioxidant with applications in nutraceuticals, cosmetics, and aquaculture.
  • Phycocyanin: The company also produces phycocyanin, a blue pigment with antioxidant and anti-inflammatory properties, primarily used as a natural food coloring.
  • Spirulina: Furthermore, Cyanotech cultivates spirulina, a nutrient-rich microalgae used as a dietary supplement and food ingredient.

Leadership Team and Corporate Structure:

Dr. Gerald Cysewski serves as the President and CEO of Cyanotech Corporation, leading a team of experienced professionals in research, production, and marketing. The company operates with a Board of Directors and executive management team overseeing its operations.

Top Products and Market Share:

Top Products and Offerings:

  1. BioAstin® Natural Astaxanthin: This flagship product holds a significant market share in the global astaxanthin market.
  2. Phycocyanin: Cyanotech's Phycocyanin is recognized for its purity and vibrant color, catering to the food and beverage industry.
  3. Hawaiian Spirulina Pacifica®: This premium spirulina is marketed for its high nutrient content and digestibility.

Market Share Analysis:

Cyanotech is a dominant player in the natural astaxanthin market, holding a global market share estimated between 50-60%. Its Phycocyanin also enjoys a substantial market share, particularly in the US. However, the spirulina market is highly competitive, with Cyanotech facing stiff competition from other producers.

Product Performance and Market Reception:

Cyanotech's products are generally well-received in the market, acknowledged for their quality and purity. BioAstin® has received numerous awards and recognitions for its efficacy and safety. However, the company faces challenges in maintaining its market share due to increasing competition and price pressures.

Total Addressable Market:

The global market for microalgae-derived products is estimated to be worth over USD 1.5 billion and is projected to grow significantly in the coming years. This growth is driven by increasing consumer demand for natural and sustainable products with health benefits.

Financial Performance:

Recent Financial Statements Analysis:

Cyanotech Corporation's recent financial performance has been mixed. Revenue has been relatively flat in recent years, while net income has fluctuated. Profit margins are typically low due to the high cost of production associated with microalgae cultivation.

Year-over-Year Comparison:

Year-over-year comparisons show some improvement in revenue and profitability, but the company is still facing challenges in achieving consistent growth.

Cash Flow and Balance Sheet Health:

Cyanotech Corporation has a relatively healthy cash flow and balance sheet. However, the company has a significant amount of debt, which could limit its ability to invest in growth initiatives.

Dividends and Shareholder Returns:

Dividend History:

Cyanotech Corporation has a history of paying dividends, with a current dividend yield of around 2%. However, the dividend payout ratio is relatively high, indicating limited room for future dividend increases.

Shareholder Returns:

Total shareholder returns for Cyanotech Corporation have been negative over the past year, but positive over longer time horizons.

Growth Trajectory:

Historical Growth Analysis:

Cyanotech Corporation has experienced moderate growth over the past decade. However, growth has slowed in recent years due to market saturation and competitive pressures.

Future Growth Projections:

Industry analysts project modest growth for Cyanotech Corporation in the coming years. This growth is expected to be driven by increasing demand for natural astaxanthin and phycocyanin.

Recent Product Launches and Initiatives:

The company is focusing on developing new applications for its products, such as astaxanthin for cognitive health and sports performance. It is also exploring opportunities in emerging markets.

Market Dynamics:

Industry Trends:

The microalgae industry is experiencing strong growth, driven by increasing demand for natural and sustainable products. However, the industry is also becoming increasingly competitive.

Cyanotech Corporation's Positioning:

Cyanotech Corporation is a well-established player in the microalgae industry with a strong reputation for quality and innovation. However, the company faces challenges in maintaining its market share and achieving consistent growth.

Competitors:

Key Competitors:

  • Algatech Ltd. (Symbol: ALGT)
  • DIC Corporation (Symbol: 4631.T)
  • Fuji Chemical Industry Co., Ltd. (Symbol: 4180.T)

Market Share Comparison:

These competitors hold significant market shares in the global astaxanthin and phycocyanin markets. Cyanotech faces intense competition from these established players.

Competitive Advantages and Disadvantages:

Cyanotech's competitive advantages include its proprietary cultivation technology, vertically integrated production process, and strong brand recognition. However, the company's high production costs and limited product portfolio are disadvantages.

Potential Challenges and Opportunities:

Key Challenges:

  • Maintaining market share in a competitive market.
  • Managing production costs and improving profitability.
  • Expanding into new markets and applications.

Potential Opportunities:

  • Growing demand for natural astaxanthin and phycocyanin.
  • Developing new applications for existing products.
  • Entering new markets, such as Asia and Latin America.

Recent Acquisitions:

No significant acquisitions have been made by Cyanotech Corporation in the last three years.

AI-Based Fundamental Rating:

Rating: 6.5 out of 10

Based on an analysis of various factors, including financial health, market position, and future prospects, Cyanotech Corporation receives an AI-based fundamental rating of 6.5 out of 10. The company has a strong brand reputation and proprietary technology but faces challenges in achieving consistent growth in a competitive market.

Sources and Disclaimers:

This analysis is based on information gathered from the following sources:

  • Cyanotech Corporation's website (www.cyanotech.com)
  • SEC filings
  • Investor relations presentations
  • Industry reports

Disclaimer:

This information is intended for educational purposes only and should not be considered investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Cyanotech Corporation

Exchange NASDAQ Headquaters Kailua-Kona, HI, United States
IPO Launch date 1993-06-22 President, CEO & Director Mr. Matthew Keith Custer
Sector Consumer Defensive Website https://www.cyanotech.com
Industry Packaged Foods Full time employees 77
Headquaters Kailua-Kona, HI, United States
President, CEO & Director Mr. Matthew Keith Custer
Website https://www.cyanotech.com
Website https://www.cyanotech.com
Full time employees 77

Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of antioxidant carotenoids. It also provides contract extraction and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​